Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Electroconvulsive Therapy | 21 | 2024 | 505 | 3.580 |
Why?
|
Delirium | 9 | 2022 | 1698 | 2.550 |
Why?
|
Natural Language Processing | 16 | 2022 | 1202 | 2.450 |
Why?
|
Electronic Health Records | 33 | 2024 | 4881 | 2.430 |
Why?
|
Restraint, Physical | 3 | 2024 | 184 | 2.330 |
Why?
|
Nursing Staff, Hospital | 4 | 2024 | 350 | 1.660 |
Why?
|
Hospitalization | 27 | 2024 | 10815 | 1.390 |
Why?
|
Hospitals, General | 4 | 2023 | 804 | 1.360 |
Why?
|
Depressive Disorder, Major | 18 | 2024 | 4813 | 1.350 |
Why?
|
Mental Disorders | 7 | 2024 | 6873 | 1.130 |
Why?
|
Inpatients | 9 | 2024 | 2563 | 1.090 |
Why?
|
Computer Security | 2 | 2018 | 261 | 1.060 |
Why?
|
Patient Readmission | 9 | 2021 | 3283 | 1.010 |
Why?
|
Patient Discharge | 9 | 2023 | 3467 | 0.940 |
Why?
|
Psychopathology | 4 | 2024 | 434 | 0.920 |
Why?
|
Confidentiality | 2 | 2018 | 607 | 0.910 |
Why?
|
Cytochrome P-450 Enzyme System | 2 | 2017 | 423 | 0.910 |
Why?
|
Prader-Willi Syndrome | 1 | 2024 | 80 | 0.890 |
Why?
|
Academic Medical Centers | 7 | 2022 | 2783 | 0.830 |
Why?
|
Ilizarov Technique | 2 | 2012 | 13 | 0.830 |
Why?
|
Ethics Consultation | 4 | 2022 | 59 | 0.700 |
Why?
|
Length of Stay | 10 | 2024 | 6489 | 0.700 |
Why?
|
Drug Discovery | 2 | 2019 | 1068 | 0.650 |
Why?
|
Hyperkalemia | 1 | 2021 | 233 | 0.640 |
Why?
|
Genetic Loci | 2 | 2019 | 2629 | 0.630 |
Why?
|
Emergency Services, Psychiatric | 1 | 2019 | 65 | 0.630 |
Why?
|
Narration | 3 | 2021 | 223 | 0.610 |
Why?
|
Humans | 159 | 2025 | 767040 | 0.580 |
Why?
|
Demography | 4 | 2023 | 1641 | 0.570 |
Why?
|
Receptors, Formyl Peptide | 1 | 2018 | 146 | 0.570 |
Why?
|
Nurse's Role | 1 | 2019 | 187 | 0.570 |
Why?
|
Behavioral Symptoms | 1 | 2019 | 188 | 0.550 |
Why?
|
Genome-Wide Association Study | 5 | 2024 | 12790 | 0.550 |
Why?
|
Diagnostic Self Evaluation | 1 | 2019 | 228 | 0.550 |
Why?
|
Consumer Health Information | 1 | 2019 | 215 | 0.550 |
Why?
|
Patient Admission | 3 | 2021 | 1364 | 0.540 |
Why?
|
Hospital Departments | 1 | 2017 | 134 | 0.540 |
Why?
|
Suicide | 2 | 2019 | 1606 | 0.540 |
Why?
|
Risk Assessment | 17 | 2024 | 24299 | 0.530 |
Why?
|
Hospitals | 8 | 2023 | 3883 | 0.530 |
Why?
|
Cation Transport Proteins | 1 | 2019 | 325 | 0.520 |
Why?
|
Retrospective Studies | 59 | 2024 | 81659 | 0.510 |
Why?
|
Catatonia | 3 | 2024 | 181 | 0.510 |
Why?
|
Female | 100 | 2025 | 396660 | 0.510 |
Why?
|
Databases, Factual | 3 | 2024 | 8068 | 0.510 |
Why?
|
Accidents | 1 | 2016 | 164 | 0.500 |
Why?
|
Premature Birth | 3 | 2023 | 1830 | 0.500 |
Why?
|
Psychotic Disorders | 4 | 2023 | 3275 | 0.490 |
Why?
|
Diagnostic and Statistical Manual of Mental Disorders | 3 | 2020 | 1987 | 0.490 |
Why?
|
Biological Specimen Banks | 2 | 2019 | 787 | 0.490 |
Why?
|
Nuclear Family | 1 | 2016 | 311 | 0.490 |
Why?
|
Bibliometrics | 1 | 2018 | 356 | 0.480 |
Why?
|
Mood Disorders | 2 | 2021 | 1129 | 0.470 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 1515 | 0.470 |
Why?
|
Early Diagnosis | 1 | 2020 | 1188 | 0.470 |
Why?
|
Obstetrics | 1 | 2021 | 679 | 0.470 |
Why?
|
Central Nervous System Agents | 1 | 2015 | 71 | 0.460 |
Why?
|
Cohort Studies | 29 | 2024 | 41718 | 0.460 |
Why?
|
Death | 1 | 2019 | 685 | 0.450 |
Why?
|
Male | 84 | 2025 | 364203 | 0.450 |
Why?
|
Education, Nursing, Continuing | 1 | 2014 | 69 | 0.450 |
Why?
|
Psychotropic Drugs | 1 | 2019 | 881 | 0.450 |
Why?
|
Middle Aged | 62 | 2025 | 223233 | 0.430 |
Why?
|
Object Attachment | 1 | 2016 | 326 | 0.430 |
Why?
|
Adult | 75 | 2025 | 223317 | 0.430 |
Why?
|
Accidental Falls | 4 | 2024 | 1079 | 0.420 |
Why?
|
Interleukins | 1 | 2018 | 796 | 0.420 |
Why?
|
Drug Interactions | 1 | 2017 | 1419 | 0.410 |
Why?
|
Drug Repositioning | 1 | 2015 | 246 | 0.410 |
Why?
|
United States | 23 | 2024 | 72971 | 0.410 |
Why?
|
Arthroplasty, Replacement, Ankle | 1 | 2012 | 26 | 0.410 |
Why?
|
Nurses | 1 | 2022 | 2501 | 0.400 |
Why?
|
Leg Length Inequality | 1 | 2012 | 56 | 0.400 |
Why?
|
Fetal Death | 1 | 2014 | 434 | 0.400 |
Why?
|
Genetic Predisposition to Disease | 4 | 2019 | 18063 | 0.400 |
Why?
|
Health Education | 1 | 2019 | 1058 | 0.390 |
Why?
|
Central Nervous System | 1 | 2019 | 1345 | 0.390 |
Why?
|
Arousal | 1 | 2018 | 1174 | 0.390 |
Why?
|
Massachusetts | 11 | 2024 | 8890 | 0.380 |
Why?
|
Insurance Claim Review | 1 | 2016 | 744 | 0.380 |
Why?
|
Diabetes Complications | 1 | 2018 | 1319 | 0.380 |
Why?
|
Medical Informatics | 1 | 2018 | 744 | 0.370 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2015 | 497 | 0.370 |
Why?
|
Models, Statistical | 5 | 2021 | 5098 | 0.360 |
Why?
|
Aged | 50 | 2024 | 171319 | 0.360 |
Why?
|
Arthrodesis | 1 | 2012 | 187 | 0.360 |
Why?
|
Databases, Genetic | 1 | 2018 | 1758 | 0.360 |
Why?
|
Forecasting | 3 | 2019 | 2936 | 0.360 |
Why?
|
Antidepressive Agents | 8 | 2024 | 2912 | 0.340 |
Why?
|
Evidence-Based Practice | 1 | 2014 | 499 | 0.330 |
Why?
|
Hospital Mortality | 7 | 2021 | 5345 | 0.330 |
Why?
|
Job Satisfaction | 3 | 2022 | 548 | 0.330 |
Why?
|
Psychiatry | 5 | 2020 | 1715 | 0.330 |
Why?
|
Internet | 3 | 2019 | 3114 | 0.330 |
Why?
|
Schizophrenia | 4 | 2024 | 6977 | 0.320 |
Why?
|
Limb Salvage | 1 | 2012 | 488 | 0.320 |
Why?
|
Arm | 1 | 2012 | 591 | 0.320 |
Why?
|
Multifactorial Inheritance | 1 | 2017 | 1422 | 0.320 |
Why?
|
Logistic Models | 12 | 2024 | 13284 | 0.320 |
Why?
|
Acute Coronary Syndrome | 2 | 2019 | 2193 | 0.310 |
Why?
|
Mortality | 2 | 2021 | 2909 | 0.310 |
Why?
|
Area Under Curve | 4 | 2021 | 1639 | 0.310 |
Why?
|
Ankle Joint | 1 | 2012 | 452 | 0.300 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2018 | 1900 | 0.300 |
Why?
|
Artificial Intelligence | 2 | 2022 | 2666 | 0.300 |
Why?
|
Adolescent | 23 | 2024 | 89046 | 0.300 |
Why?
|
Schizophrenic Psychology | 1 | 2015 | 1647 | 0.290 |
Why?
|
Phenotype | 4 | 2024 | 16718 | 0.290 |
Why?
|
North Carolina | 8 | 2025 | 329 | 0.280 |
Why?
|
Leg | 1 | 2012 | 1087 | 0.280 |
Why?
|
Postpartum Hemorrhage | 2 | 2021 | 275 | 0.280 |
Why?
|
Hospice Care | 1 | 2014 | 678 | 0.280 |
Why?
|
Labor Stage, Second | 2 | 2024 | 45 | 0.280 |
Why?
|
Body Dysmorphic Disorders | 2 | 2022 | 242 | 0.270 |
Why?
|
Aged, 80 and over | 25 | 2024 | 59548 | 0.270 |
Why?
|
Osteoarthritis | 1 | 2015 | 1072 | 0.270 |
Why?
|
Myocardial Ischemia | 1 | 2017 | 2131 | 0.270 |
Why?
|
Cognition | 5 | 2022 | 7059 | 0.270 |
Why?
|
Pregnancy Complications | 3 | 2024 | 2971 | 0.270 |
Why?
|
Pregnancy | 15 | 2024 | 30238 | 0.270 |
Why?
|
Cause of Death | 2 | 2016 | 3717 | 0.260 |
Why?
|
Frail Elderly | 4 | 2022 | 781 | 0.260 |
Why?
|
Anxiety Disorders | 1 | 2017 | 2745 | 0.260 |
Why?
|
New England | 3 | 2018 | 1058 | 0.260 |
Why?
|
Genetic Variation | 2 | 2018 | 6611 | 0.250 |
Why?
|
Respiration, Artificial | 3 | 2022 | 2726 | 0.250 |
Why?
|
Seizures | 5 | 2021 | 2996 | 0.250 |
Why?
|
Language | 3 | 2025 | 1550 | 0.250 |
Why?
|
Osteogenesis, Distraction | 3 | 2012 | 233 | 0.250 |
Why?
|
Mothers | 1 | 2016 | 2209 | 0.250 |
Why?
|
Safety Management | 2 | 2021 | 765 | 0.250 |
Why?
|
Workplace | 2 | 2021 | 873 | 0.240 |
Why?
|
Dementia | 1 | 2020 | 2741 | 0.240 |
Why?
|
Personality Disorders | 2 | 2020 | 726 | 0.240 |
Why?
|
ROC Curve | 6 | 2024 | 3618 | 0.240 |
Why?
|
Carrier Proteins | 1 | 2018 | 4925 | 0.240 |
Why?
|
Treatment Outcome | 24 | 2024 | 65295 | 0.230 |
Why?
|
Borderline Personality Disorder | 2 | 2022 | 767 | 0.230 |
Why?
|
National Institute of Mental Health (U.S.) | 1 | 2024 | 108 | 0.230 |
Why?
|
Social Support | 1 | 2014 | 2192 | 0.220 |
Why?
|
Risk Factors | 21 | 2024 | 74886 | 0.220 |
Why?
|
Risk-Taking | 5 | 2017 | 1023 | 0.220 |
Why?
|
Apgar Score | 1 | 2024 | 126 | 0.220 |
Why?
|
Lorazepam | 1 | 2024 | 155 | 0.220 |
Why?
|
Emotions | 1 | 2015 | 2760 | 0.220 |
Why?
|
Universities | 4 | 2009 | 1004 | 0.220 |
Why?
|
Disease Progression | 2 | 2020 | 13646 | 0.210 |
Why?
|
Alcoholic Intoxication | 3 | 2009 | 171 | 0.210 |
Why?
|
Clinical Coding | 1 | 2024 | 187 | 0.200 |
Why?
|
Child | 11 | 2024 | 80771 | 0.200 |
Why?
|
Orthopedic Procedures | 1 | 2012 | 1279 | 0.200 |
Why?
|
External Fixators | 2 | 2012 | 99 | 0.200 |
Why?
|
Communication | 1 | 2016 | 3904 | 0.190 |
Why?
|
Mental Fatigue | 1 | 2021 | 23 | 0.190 |
Why?
|
Life Support Care | 1 | 2023 | 226 | 0.190 |
Why?
|
Health Personnel | 3 | 2020 | 3387 | 0.190 |
Why?
|
Labor, Obstetric | 2 | 2021 | 313 | 0.190 |
Why?
|
Angiotensins | 1 | 2021 | 140 | 0.180 |
Why?
|
Vermont | 1 | 2020 | 80 | 0.180 |
Why?
|
Cross-Sectional Studies | 12 | 2022 | 26325 | 0.180 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2024 | 497 | 0.180 |
Why?
|
Patients' Rooms | 1 | 2021 | 63 | 0.180 |
Why?
|
Illinois | 1 | 2020 | 120 | 0.180 |
Why?
|
Comorbidity | 8 | 2024 | 10582 | 0.170 |
Why?
|
Surgery Department, Hospital | 1 | 2021 | 170 | 0.170 |
Why?
|
Cholinergic Antagonists | 1 | 2021 | 166 | 0.170 |
Why?
|
Pregnancy Trimester, Third | 1 | 2023 | 587 | 0.170 |
Why?
|
Labor, Induced | 1 | 2021 | 153 | 0.170 |
Why?
|
Pregnancy Trimester, Second | 1 | 2023 | 737 | 0.170 |
Why?
|
Bone Neoplasms | 1 | 2012 | 2563 | 0.170 |
Why?
|
Internal Medicine | 2 | 2017 | 1064 | 0.170 |
Why?
|
Bipolar Disorder | 3 | 2021 | 5130 | 0.160 |
Why?
|
Patient Care Team | 2 | 2021 | 2516 | 0.160 |
Why?
|
Nursing Care | 1 | 2019 | 65 | 0.160 |
Why?
|
Genotype | 3 | 2019 | 13035 | 0.160 |
Why?
|
Intention | 1 | 2022 | 347 | 0.160 |
Why?
|
Resilience, Psychological | 2 | 2017 | 807 | 0.160 |
Why?
|
Self-Assessment | 1 | 2021 | 400 | 0.160 |
Why?
|
SEER Program | 1 | 2024 | 1444 | 0.160 |
Why?
|
Students | 4 | 2009 | 1744 | 0.160 |
Why?
|
Workload | 1 | 2024 | 849 | 0.150 |
Why?
|
Critical Illness | 2 | 2022 | 2753 | 0.150 |
Why?
|
Prescriptions | 1 | 2021 | 388 | 0.150 |
Why?
|
Young Adult | 15 | 2024 | 59980 | 0.150 |
Why?
|
Burnout, Professional | 2 | 2017 | 711 | 0.150 |
Why?
|
Delivery of Health Care | 1 | 2016 | 5363 | 0.150 |
Why?
|
Psychomotor Agitation | 1 | 2020 | 307 | 0.150 |
Why?
|
Risk | 3 | 2019 | 9606 | 0.150 |
Why?
|
Vaccination | 3 | 2025 | 3434 | 0.150 |
Why?
|
Aerosols | 1 | 2020 | 634 | 0.140 |
Why?
|
Mandatory Reporting | 1 | 2018 | 123 | 0.140 |
Why?
|
Quality of Life | 5 | 2024 | 13485 | 0.140 |
Why?
|
Heart Failure | 2 | 2022 | 11877 | 0.140 |
Why?
|
Hypertension, Pregnancy-Induced | 1 | 2023 | 529 | 0.140 |
Why?
|
Prevalence | 5 | 2018 | 15851 | 0.140 |
Why?
|
Organizational Culture | 1 | 2021 | 513 | 0.140 |
Why?
|
Child, Preschool | 4 | 2024 | 42606 | 0.140 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2020 | 418 | 0.140 |
Why?
|
Physicians | 4 | 2021 | 4593 | 0.140 |
Why?
|
Insurance Claim Reporting | 1 | 2017 | 166 | 0.140 |
Why?
|
California | 1 | 2020 | 1439 | 0.130 |
Why?
|
Radiosurgery | 3 | 2012 | 1330 | 0.130 |
Why?
|
Clostridium Infections | 1 | 2023 | 562 | 0.130 |
Why?
|
Anesthetics | 1 | 2021 | 525 | 0.130 |
Why?
|
Antimanic Agents | 1 | 2019 | 524 | 0.130 |
Why?
|
Suicidal Ideation | 2 | 2023 | 1467 | 0.120 |
Why?
|
Current Procedural Terminology | 1 | 2016 | 101 | 0.120 |
Why?
|
Delivery, Obstetric | 4 | 2024 | 949 | 0.120 |
Why?
|
Occupational Health | 1 | 2021 | 812 | 0.120 |
Why?
|
Infant | 4 | 2024 | 36485 | 0.120 |
Why?
|
Attitude | 1 | 2020 | 769 | 0.120 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2021 | 1065 | 0.120 |
Why?
|
Clinical Protocols | 1 | 2020 | 1443 | 0.120 |
Why?
|
Kaplan-Meier Estimate | 5 | 2017 | 6513 | 0.110 |
Why?
|
Time Factors | 8 | 2023 | 40154 | 0.110 |
Why?
|
Follow-Up Studies | 12 | 2019 | 39317 | 0.110 |
Why?
|
Education, Continuing | 1 | 2015 | 115 | 0.110 |
Why?
|
Self Report | 5 | 2023 | 3773 | 0.110 |
Why?
|
Longitudinal Studies | 5 | 2024 | 14766 | 0.110 |
Why?
|
Teaching | 1 | 2021 | 1172 | 0.110 |
Why?
|
Insurance | 1 | 2015 | 115 | 0.110 |
Why?
|
Internship and Residency | 3 | 2020 | 5947 | 0.110 |
Why?
|
Brain Diseases | 1 | 2022 | 1551 | 0.110 |
Why?
|
Health Promotion | 2 | 2016 | 2210 | 0.110 |
Why?
|
Probability | 1 | 2018 | 2476 | 0.110 |
Why?
|
Chemotherapy, Adjuvant | 3 | 2024 | 3552 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3112 | 0.100 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2020 | 996 | 0.100 |
Why?
|
Drug Prescriptions | 1 | 2022 | 1664 | 0.100 |
Why?
|
Pre-Eclampsia | 1 | 2022 | 1255 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3234 | 0.100 |
Why?
|
Occupational Diseases | 1 | 2020 | 1456 | 0.100 |
Why?
|
Appendiceal Neoplasms | 1 | 2014 | 155 | 0.100 |
Why?
|
Neoadjuvant Therapy | 1 | 2024 | 2902 | 0.100 |
Why?
|
Hip Prosthesis | 2 | 1989 | 924 | 0.100 |
Why?
|
Delayed Diagnosis | 1 | 2016 | 454 | 0.100 |
Why?
|
Mother-Child Relations | 1 | 2016 | 498 | 0.100 |
Why?
|
Lithium | 1 | 2015 | 600 | 0.100 |
Why?
|
Infant, Newborn | 5 | 2024 | 26396 | 0.100 |
Why?
|
Angiogenesis Inhibitors | 2 | 2014 | 2055 | 0.100 |
Why?
|
Osteotomy | 2 | 2020 | 837 | 0.100 |
Why?
|
Leadership | 1 | 2021 | 1394 | 0.100 |
Why?
|
Disease | 1 | 2017 | 675 | 0.100 |
Why?
|
Feasibility Studies | 2 | 2024 | 5311 | 0.100 |
Why?
|
Substance-Related Disorders | 2 | 2019 | 4422 | 0.100 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2021 | 6023 | 0.100 |
Why?
|
Principal Component Analysis | 1 | 2015 | 950 | 0.090 |
Why?
|
Intensive Care Units | 2 | 2022 | 3797 | 0.090 |
Why?
|
Severity of Illness Index | 5 | 2024 | 15925 | 0.090 |
Why?
|
Medical Records | 1 | 2016 | 1409 | 0.090 |
Why?
|
Trigeminal Neuralgia | 1 | 2012 | 103 | 0.090 |
Why?
|
Models, Psychological | 1 | 2015 | 823 | 0.090 |
Why?
|
Hyperthermia, Induced | 1 | 2014 | 414 | 0.090 |
Why?
|
Organ Transplantation | 1 | 2021 | 1173 | 0.090 |
Why?
|
Data Collection | 1 | 2020 | 3321 | 0.090 |
Why?
|
Europe | 1 | 2017 | 3432 | 0.090 |
Why?
|
Humerus | 1 | 2012 | 273 | 0.090 |
Why?
|
Critical Care | 1 | 2023 | 2714 | 0.090 |
Why?
|
Recurrence | 2 | 2023 | 8504 | 0.090 |
Why?
|
Pilot Projects | 3 | 2019 | 8732 | 0.090 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 2270 | 0.090 |
Why?
|
Angiotensin I | 1 | 2009 | 47 | 0.090 |
Why?
|
Oxidation-Reduction | 1 | 2016 | 2221 | 0.080 |
Why?
|
New York City | 1 | 2012 | 736 | 0.080 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2015 | 1331 | 0.080 |
Why?
|
Reproducibility of Results | 5 | 2022 | 20169 | 0.080 |
Why?
|
AIDS Serodiagnosis | 1 | 2011 | 220 | 0.080 |
Why?
|
Renal Insufficiency | 1 | 2015 | 812 | 0.080 |
Why?
|
Pregnancy Outcome | 4 | 2024 | 2972 | 0.080 |
Why?
|
Information Storage and Retrieval | 1 | 2015 | 833 | 0.080 |
Why?
|
Geriatric Assessment | 1 | 2017 | 1422 | 0.080 |
Why?
|
Southeastern United States | 2 | 2021 | 93 | 0.080 |
Why?
|
Thalidomide | 1 | 2014 | 886 | 0.080 |
Why?
|
Anesthesia | 1 | 2020 | 1595 | 0.080 |
Why?
|
Community-Based Participatory Research | 1 | 2011 | 223 | 0.080 |
Why?
|
Parity | 2 | 2023 | 931 | 0.080 |
Why?
|
Research Design | 3 | 2024 | 6210 | 0.080 |
Why?
|
Choroid Neoplasms | 1 | 2010 | 177 | 0.080 |
Why?
|
Diagnostic Errors | 1 | 2016 | 1278 | 0.080 |
Why?
|
Exercise | 2 | 2018 | 5954 | 0.080 |
Why?
|
Alcoholism | 1 | 2019 | 1980 | 0.080 |
Why?
|
Bone Diseases | 1 | 2012 | 416 | 0.080 |
Why?
|
Sleep | 1 | 2024 | 4816 | 0.080 |
Why?
|
Wounds and Injuries | 2 | 2014 | 2513 | 0.070 |
Why?
|
Peritoneal Neoplasms | 1 | 2014 | 706 | 0.070 |
Why?
|
Prospective Studies | 6 | 2024 | 54886 | 0.070 |
Why?
|
Cluster Analysis | 1 | 2015 | 2721 | 0.070 |
Why?
|
Adolescent Behavior | 1 | 2016 | 1188 | 0.070 |
Why?
|
Medication Adherence | 1 | 2019 | 2191 | 0.070 |
Why?
|
Walking | 1 | 2015 | 1201 | 0.070 |
Why?
|
Survival Analysis | 2 | 2019 | 10092 | 0.070 |
Why?
|
Recreation | 1 | 2008 | 124 | 0.070 |
Why?
|
Ovarian Neoplasms | 1 | 2024 | 4903 | 0.070 |
Why?
|
Regression Analysis | 1 | 2016 | 6331 | 0.070 |
Why?
|
Prognosis | 6 | 2023 | 29963 | 0.070 |
Why?
|
Tibia | 1 | 2012 | 1075 | 0.070 |
Why?
|
Clinical Competence | 2 | 2019 | 4859 | 0.070 |
Why?
|
Emergency Service, Hospital | 2 | 2024 | 7871 | 0.070 |
Why?
|
Models, Biological | 2 | 2021 | 9464 | 0.070 |
Why?
|
Age Factors | 2 | 2020 | 18401 | 0.070 |
Why?
|
Pandemics | 3 | 2022 | 8736 | 0.070 |
Why?
|
Cost of Illness | 1 | 2016 | 1951 | 0.070 |
Why?
|
Social Environment | 2 | 2009 | 1012 | 0.070 |
Why?
|
Iodine Radioisotopes | 1 | 2010 | 1029 | 0.070 |
Why?
|
Insurance, Health | 1 | 2018 | 2519 | 0.060 |
Why?
|
Antipsychotic Agents | 1 | 2019 | 3078 | 0.060 |
Why?
|
Sensitivity and Specificity | 1 | 2021 | 14672 | 0.060 |
Why?
|
Anxiety | 1 | 2020 | 4670 | 0.060 |
Why?
|
Models, Theoretical | 1 | 2017 | 3561 | 0.060 |
Why?
|
Lymphedema | 1 | 2011 | 526 | 0.060 |
Why?
|
Neuropsychological Tests | 1 | 2018 | 7121 | 0.060 |
Why?
|
Glomerular Filtration Rate | 2 | 2015 | 2227 | 0.060 |
Why?
|
Models, Nursing | 1 | 2024 | 47 | 0.060 |
Why?
|
Opioid-Related Disorders | 1 | 2019 | 2188 | 0.060 |
Why?
|
Cardiotocography | 1 | 2024 | 33 | 0.060 |
Why?
|
Decision Support Techniques | 1 | 2014 | 2006 | 0.060 |
Why?
|
Gestational Age | 2 | 2024 | 3618 | 0.060 |
Why?
|
Case-Control Studies | 2 | 2022 | 22254 | 0.060 |
Why?
|
Hypertension | 2 | 2022 | 8615 | 0.060 |
Why?
|
Curriculum | 1 | 2017 | 3786 | 0.060 |
Why?
|
Family | 1 | 2015 | 3210 | 0.060 |
Why?
|
International Classification of Diseases | 2 | 2020 | 935 | 0.060 |
Why?
|
Analgesics, Opioid | 1 | 2020 | 3837 | 0.060 |
Why?
|
Health Care Costs | 1 | 2017 | 3239 | 0.050 |
Why?
|
Vascular Neoplasms | 1 | 2005 | 167 | 0.050 |
Why?
|
Peer Group | 1 | 2009 | 702 | 0.050 |
Why?
|
Mastectomy | 1 | 2011 | 1861 | 0.050 |
Why?
|
Football | 1 | 2009 | 504 | 0.050 |
Why?
|
Incidence | 1 | 2021 | 21526 | 0.050 |
Why?
|
Homosexuality, Male | 1 | 2011 | 1344 | 0.050 |
Why?
|
Pregnancy Rate | 1 | 2005 | 655 | 0.050 |
Why?
|
Brachytherapy | 1 | 2010 | 1220 | 0.050 |
Why?
|
Obstetric Labor Complications | 1 | 2024 | 240 | 0.050 |
Why?
|
Hospitals, Psychiatric | 1 | 2023 | 317 | 0.050 |
Why?
|
Vena Cava, Inferior | 1 | 2005 | 463 | 0.050 |
Why?
|
Obesity | 1 | 2024 | 13085 | 0.050 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12536 | 0.050 |
Why?
|
Telemedicine | 1 | 2019 | 3110 | 0.050 |
Why?
|
Thiopental | 1 | 2021 | 55 | 0.050 |
Why?
|
Catheter-Related Infections | 1 | 2024 | 277 | 0.050 |
Why?
|
Depression | 4 | 2024 | 8234 | 0.050 |
Why?
|
Leiomyosarcoma | 1 | 2005 | 426 | 0.050 |
Why?
|
Ethicists | 1 | 2021 | 39 | 0.050 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2005 | 503 | 0.050 |
Why?
|
Hydro-Lyases | 1 | 2020 | 93 | 0.040 |
Why?
|
Blood Urea Nitrogen | 1 | 2020 | 189 | 0.040 |
Why?
|
Cardiopulmonary Bypass | 1 | 2006 | 1097 | 0.040 |
Why?
|
Maintenance | 1 | 2020 | 25 | 0.040 |
Why?
|
Waist Circumference | 1 | 2024 | 935 | 0.040 |
Why?
|
Erythrocyte Count | 1 | 2020 | 157 | 0.040 |
Why?
|
Actigraphy | 1 | 2024 | 527 | 0.040 |
Why?
|
Atherosclerosis | 2 | 2006 | 3418 | 0.040 |
Why?
|
Adolescent Psychiatry | 1 | 2021 | 165 | 0.040 |
Why?
|
Algorithms | 2 | 2021 | 14098 | 0.040 |
Why?
|
Biological Transport | 1 | 2024 | 2084 | 0.040 |
Why?
|
Aorta, Thoracic | 1 | 2006 | 1110 | 0.040 |
Why?
|
Postoperative Complications | 2 | 2012 | 15824 | 0.040 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2019 | 16036 | 0.040 |
Why?
|
Paroxetine | 1 | 2020 | 181 | 0.040 |
Why?
|
Disease-Free Survival | 4 | 2014 | 6844 | 0.040 |
Why?
|
Withholding Treatment | 1 | 2023 | 619 | 0.040 |
Why?
|
Eligibility Determination | 1 | 2022 | 421 | 0.040 |
Why?
|
Resuscitation Orders | 1 | 2020 | 271 | 0.040 |
Why?
|
Infant, Newborn, Diseases | 1 | 2024 | 587 | 0.040 |
Why?
|
Lower Extremity | 1 | 2006 | 1217 | 0.040 |
Why?
|
Lymphocyte Count | 1 | 2020 | 793 | 0.040 |
Why?
|
Anesthetics, Intravenous | 1 | 2021 | 396 | 0.040 |
Why?
|
Emigrants and Immigrants | 1 | 2025 | 550 | 0.040 |
Why?
|
Kidney Diseases | 1 | 2008 | 2099 | 0.040 |
Why?
|
Platelet Count | 1 | 2020 | 784 | 0.040 |
Why?
|
Parturition | 1 | 2021 | 454 | 0.040 |
Why?
|
Brain Neoplasms | 2 | 2010 | 9108 | 0.040 |
Why?
|
Infant, Low Birth Weight | 1 | 2022 | 871 | 0.040 |
Why?
|
HIV Infections | 2 | 2016 | 17542 | 0.030 |
Why?
|
Peptide Fragments | 1 | 2009 | 5141 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 2014 | 6360 | 0.030 |
Why?
|
Policy | 1 | 2020 | 513 | 0.030 |
Why?
|
Neoplasm Staging | 3 | 2024 | 11217 | 0.030 |
Why?
|
Education, Medical, Graduate | 2 | 2020 | 2420 | 0.030 |
Why?
|
Hydrocortisone | 1 | 2024 | 1840 | 0.030 |
Why?
|
Mass Screening | 2 | 2016 | 5456 | 0.030 |
Why?
|
Morphine | 1 | 2020 | 658 | 0.030 |
Why?
|
Eosinophils | 1 | 2020 | 951 | 0.030 |
Why?
|
Electroencephalography | 2 | 2021 | 6282 | 0.030 |
Why?
|
Troponin T | 1 | 2020 | 786 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2022 | 856 | 0.030 |
Why?
|
Prenatal Care | 1 | 2023 | 1158 | 0.030 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 746 | 0.030 |
Why?
|
Fatigue | 1 | 2022 | 1556 | 0.030 |
Why?
|
Alcohol Drinking | 1 | 2008 | 4045 | 0.030 |
Why?
|
Creatinine | 1 | 2020 | 1916 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2014 | 6966 | 0.030 |
Why?
|
Body Mass Index | 2 | 2024 | 13048 | 0.030 |
Why?
|
Infusions, Parenteral | 1 | 2014 | 395 | 0.030 |
Why?
|
Remission Induction | 1 | 2020 | 2408 | 0.030 |
Why?
|
Medicare | 2 | 2024 | 6813 | 0.030 |
Why?
|
Medically Uninsured | 1 | 2019 | 838 | 0.030 |
Why?
|
Prenatal Diagnosis | 1 | 2021 | 1271 | 0.030 |
Why?
|
Body Weight | 1 | 2024 | 4627 | 0.030 |
Why?
|
Radiotherapy Dosage | 2 | 2010 | 2915 | 0.030 |
Why?
|
Patient Education as Topic | 2 | 2015 | 2337 | 0.030 |
Why?
|
Prosthesis Failure | 2 | 1989 | 1208 | 0.030 |
Why?
|
Energy Metabolism | 1 | 2024 | 2906 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2021 | 2353 | 0.030 |
Why?
|
Radiotherapy, Adjuvant | 2 | 2010 | 1788 | 0.030 |
Why?
|
Heart Diseases | 1 | 2006 | 2817 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2022 | 10393 | 0.030 |
Why?
|
Smoking | 1 | 2009 | 9081 | 0.020 |
Why?
|
Health Services Needs and Demand | 1 | 2019 | 1405 | 0.020 |
Why?
|
Monitoring, Ambulatory | 1 | 2015 | 357 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2014 | 13650 | 0.020 |
Why?
|
Nausea | 1 | 2014 | 682 | 0.020 |
Why?
|
Melanoma | 1 | 2010 | 5702 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2020 | 6067 | 0.020 |
Why?
|
Vomiting | 1 | 2014 | 655 | 0.020 |
Why?
|
Monocytes | 1 | 2020 | 2598 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2015 | 12250 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2024 | 3928 | 0.020 |
Why?
|
Eye Enucleation | 1 | 2010 | 128 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2008 | 7469 | 0.020 |
Why?
|
Analysis of Variance | 2 | 2010 | 6215 | 0.020 |
Why?
|
Self Care | 1 | 2015 | 800 | 0.020 |
Why?
|
Decision Making | 1 | 2023 | 3951 | 0.020 |
Why?
|
Amikacin | 1 | 2008 | 48 | 0.020 |
Why?
|
Neoplasms | 2 | 2009 | 22350 | 0.020 |
Why?
|
Bisexuality | 1 | 2011 | 295 | 0.020 |
Why?
|
Tobramycin | 1 | 2008 | 65 | 0.020 |
Why?
|
Stress, Psychological | 1 | 2024 | 4526 | 0.020 |
Why?
|
Odds Ratio | 2 | 2014 | 9660 | 0.020 |
Why?
|
Glucose | 1 | 2020 | 4341 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2020 | 3851 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2006 | 9410 | 0.020 |
Why?
|
Body Surface Area | 1 | 2008 | 206 | 0.020 |
Why?
|
Physical Therapy Modalities | 1 | 2011 | 533 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2011 | 1587 | 0.020 |
Why?
|
Thromboembolism | 1 | 2014 | 1003 | 0.020 |
Why?
|
Gentamicins | 1 | 2008 | 244 | 0.020 |
Why?
|
Cultural Competency | 1 | 2011 | 303 | 0.020 |
Why?
|
Neutrophils | 1 | 2020 | 3779 | 0.020 |
Why?
|
Health Surveys | 2 | 2009 | 4056 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2009 | 10748 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2009 | 1002 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2019 | 3618 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 1989 | 1623 | 0.020 |
Why?
|
Periodicity | 1 | 2008 | 347 | 0.020 |
Why?
|
New York | 1 | 1989 | 879 | 0.020 |
Why?
|
Locomotion | 1 | 1988 | 388 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2012 | 12069 | 0.020 |
Why?
|
Linear Models | 1 | 2015 | 5875 | 0.020 |
Why?
|
Retreatment | 1 | 2006 | 598 | 0.020 |
Why?
|
Quality Improvement | 1 | 2020 | 3854 | 0.010 |
Why?
|
Birth Rate | 1 | 2005 | 168 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2011 | 21178 | 0.010 |
Why?
|
Tumor Burden | 1 | 2010 | 1903 | 0.010 |
Why?
|
Nervous System Diseases | 1 | 2014 | 1660 | 0.010 |
Why?
|
Brain | 1 | 2010 | 27163 | 0.010 |
Why?
|
Radiation Dosage | 1 | 2012 | 1965 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2009 | 3431 | 0.010 |
Why?
|
Automobile Driving | 1 | 2008 | 442 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2014 | 8535 | 0.010 |
Why?
|
Minority Groups | 1 | 2009 | 1214 | 0.010 |
Why?
|
Sex Offenses | 1 | 2006 | 355 | 0.010 |
Why?
|
Hip Joint | 1 | 1988 | 1017 | 0.010 |
Why?
|
Embryo Transfer | 1 | 2005 | 527 | 0.010 |
Why?
|
Patient Compliance | 1 | 2011 | 2697 | 0.010 |
Why?
|
Movement | 1 | 1988 | 1473 | 0.010 |
Why?
|
Prosthesis Design | 1 | 1988 | 2120 | 0.010 |
Why?
|
Sex Distribution | 1 | 2006 | 2276 | 0.010 |
Why?
|
Postoperative Period | 1 | 2006 | 1824 | 0.010 |
Why?
|
Treatment Failure | 1 | 2006 | 2658 | 0.010 |
Why?
|
Interpersonal Relations | 1 | 2008 | 1432 | 0.010 |
Why?
|
Visual Acuity | 1 | 2010 | 2714 | 0.010 |
Why?
|
Causality | 1 | 2006 | 1253 | 0.010 |
Why?
|
Age Distribution | 1 | 2005 | 2870 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2009 | 2116 | 0.010 |
Why?
|
Dyslipidemias | 1 | 2006 | 872 | 0.010 |
Why?
|
Activities of Daily Living | 1 | 1988 | 2429 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2008 | 2698 | 0.010 |
Why?
|
Reoperation | 1 | 1988 | 4325 | 0.010 |
Why?
|
Peptides | 1 | 2009 | 4348 | 0.010 |
Why?
|
Radiography | 1 | 1988 | 6975 | 0.010 |
Why?
|
Diabetes Mellitus | 1 | 2015 | 5886 | 0.010 |
Why?
|
Survival Rate | 1 | 2010 | 12823 | 0.010 |
Why?
|
Vascular Surgical Procedures | 1 | 2005 | 1506 | 0.010 |
Why?
|
Myocardial Infarction | 1 | 2016 | 11513 | 0.010 |
Why?
|
Sex Factors | 1 | 2009 | 10622 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2012 | 15424 | 0.010 |
Why?
|
Blood Vessel Prosthesis Implantation | 1 | 2005 | 1456 | 0.010 |
Why?
|
Pain | 1 | 1988 | 5101 | 0.010 |
Why?
|
Cardiac Surgical Procedures | 1 | 2006 | 3683 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2010 | 36582 | 0.000 |
Why?
|
Cardiovascular Diseases | 1 | 2006 | 15645 | 0.000 |
Why?
|